SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-08-071720
Filing Date
2008-04-01
Accepted
2008-04-01 06:06:30
Documents
8
Period of Report
2008-05-07
Effectiveness Date
2008-04-01

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 1104675
2 GRAPHIC g13584amgen_letterhead.jpg GRAPHIC 21657
3 GRAPHIC g13584david_scott.jpg GRAPHIC 8476
4 GRAPHIC g13584g20d54.jpg GRAPHIC 37930
5 GRAPHIC g13584g26e52.jpg GRAPHIC 39105
6 GRAPHIC g13584kevin_sharer.jpg GRAPHIC 6560
7 GRAPHIC g13584letterhead_002.jpg GRAPHIC 16940
8 GRAPHIC g13584recycle_symbol.jpg GRAPHIC 2556
  Complete submission text file 0001193125-08-071720.txt   1290893
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-12477 | Film No.: 08727247
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1